Literature DB >> 7216424

Neutralizing activity against Clostridium difficile toxin in the supernatants of cultured colostral cells.

N Wada, N Nishida, S Iwaki, H Ohi, T Miyawaki, N Taniguchi, S Migita.   

Abstract

Human colostral specimens were obtained from 60 Japanese postpartum women within the first 3 days after delivery. Neutralizing activity against Clostridium difficile toxin was evaluated with Y1 adrenal cells in miniculture. When Y1 adrenal cells were exposed briefly to the toxin, they showed a rounding response in culture, resembling that effected by Escherichia coli enterotoxin; however, preincubation of the toxin with aqueous phase of colostrum significantly reduced its cytopathic effect on Y1 adrenal cells. Of 60 colostral specimens, 17 samples had neutralizing activity against the toxin. Cell-free supernatants of colostral cells cultured for 7 days without mitogens contained significant amounts of both immunoglobulin A (IgA) and IgM, but very small amounts of IgG. Neutralizing activity of cell-free supernatants of cultured colostral cells was evaluated as described above. Neutralizing activity against the toxin was identified in five samples of culture supernatants out of 60 colostral cell specimens. In all five cases, the aqueous phase of colostrum also had a neutralizing effect against C. difficile toxin. Neutralizing activity against the toxin found in five supernatants of cultured colostral cells was completely abolished only by anti-human IgA antibody as assessed by immune precipitation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7216424      PMCID: PMC551153          DOI: 10.1128/iai.29.2.545-550.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Protection against experimental necrotizing enterocolitis by maternal milk. I. Role of milk leukocytes.

Authors:  J Pitt; B Barlow; W C Heird
Journal:  Pediatr Res       Date:  1977-08       Impact factor: 3.756

2.  An experimental study of acute neonatal enterocolitis--the importance of breast milk.

Authors:  B Barlow; T V Santulli; W C Heird; J Pitt; W A Blanc; J N Schullinger
Journal:  J Pediatr Surg       Date:  1974-10       Impact factor: 2.545

3.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

4.  Phagocytosis in the newborn infant: humoral and cellular factors.

Authors:  M E Miller
Journal:  J Pediatr       Date:  1969-02       Impact factor: 4.406

5.  Synthesis of secretory IgA by human colostral cells.

Authors:  G J Murillo
Journal:  South Med J       Date:  1971-11       Impact factor: 0.954

6.  Antibody production by human colostral cells. I. Immunoglobulin class, specificity, and quantity.

Authors:  S Ahlstedt; B Carlsson; L A Hanson; R M Goldblum
Journal:  Scand J Immunol       Date:  1975-09       Impact factor: 3.487

7.  The antimicrobial activity of human colostral antibody in the newborn.

Authors:  J G Michael; R Ringenback; S Hottenstein
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

8.  Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture.

Authors:  D A Sack; R B Sack
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

9.  Neutralizing antibodies against Escherichia coli and Vibrio cholerae enterotoxins in human milk from a developing country.

Authors:  J Holmgren; L A Hanson; B Carlson; B S Lindblad; J Rahimtoola
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

View more
  5 in total

Review 1.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

Authors:  W A Flegel; F Müller; W Däubener; H G Fischer; U Hadding; H Northoff
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

3.  Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.

Authors:  P J Giannasca; Z X Zhang; W D Lei; J A Boden; M A Giel; T P Monath; W D Thomas
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  New advances in the treatment of Clostridium difficile infection (CDI).

Authors:  Dennis D Hedge; Joe D Strain; Jodi R Heins; Debra K Farver
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

5.  Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.

Authors:  Chandrabali Ghose; Ioannis Eugenis; Xingmin Sun; Adrianne N Edwards; Shonna M McBride; David T Pride; Ciarán P Kelly; David D Ho
Journal:  Emerg Microbes Infect       Date:  2016-02-03       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.